Increasing evidence indicates that tumor microenvironment (TME) is crucial in tumor survival and metastases. Inflammatory cells accumulate around tumors and strangely appear to be permissive to their growth. One key stroma cell is the mast cell (MC), which can secrete numerous pro-and antitumor molecules. We investigated the presence and degranulation state of MC in pancreatic ductal adenocarcinoma (PDAC) as compared to acute pancreatitis (AP). Three different detection methods: (a) toluidine blue staining, as well as immunohistochemistry for (b) tryptase and (c) c-kit, were utilized to assess the number and extent of degranulation of MC in PDAC tissue (n=7), uninvolved pancreatic tissue derived from tumor-free margins (n=7) and tissue form AP (n=4). The number of MC detected with all three methods was significantly increased in PDAC, as compared to normal pancreatic tissue derived from tumor-free margins (p<O.05). The highest number of MC was identified by c-kit, 22 .2±7.5 per high power field (HPF) in PDAC vs 9.7±5.1 per HPF in normal tissue. Contrary to MC in AP, where most of the detected MC were found degranulated, MC in PDAC appeared intact. In conclusion, MC are increased in number, but not degranulated in PDAC, suggesting that they may contribute to cancer growth by permitting selective release of pro-tumorogenic molecules.
Pancreatic ductal adenocarcinoma (PDAC), ranked fourth among the cancer-related causes of death in the US, has the lowest survival rate of all cancer types with mean survival time of 3-6 months and 5-year survival less than 5% (I). This outcome is largely attributed to the PDAC tumor microenvironment (TME) that includes fibroblasts, macrophages and mast cells (MC), which apparently playa key role in facilitating cancer growth (2) (3) (4) . The TME also raises an immunosuppressive "barrier" to antitumor immune responses, and may also interfere with therapeutic modalities including conventional chemotherapy, targeted agents and immunotherapy (5, 6) .
MC infiltration ofhuman PDAC seems to correlate with tumor aggressiveness (7, 8) . New evidence suggests that MC are essential for impairing both the generation of protective antitumor T cell response, as well as the intratumor T cell accumulation (9) . In fact, some genetic polymorphisms associated with inflammatory responses have been implicated in increased cancer risk (10) , supporting the speculation that inflammation augments cancer growth (11, 12) . This is particularly evident from the notably higher incidence of PDAC in patients with pre-existing inflammatory conditions, such as chronic (13) and hereditary (14) pancreatitis.
Several mouse models of inducible and spontaneous cancers suggest that MC are among the first immune cells to accumulate within and contribute to the TME (2, 3, 6) . In addition, MC constitute an absolute requirement for tumor angiogenesis and cancer development in Myc-activated mouse pancreatic tumors (15) . Metastastatic tumors, which are the main cause of cancer morbidity and mortality, appear to be also regulated by stromal proteolytic enzymes (4) and chemokines (16) secreted by TME cells. Molecules secreted from MC include heparin, metalloproteinases, platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF); these have been considered as possessing a "protumorogenic" capacity (2) . We have previously shown that VEGF is selectively secreted by human MC in response to corticotropin-releasing hormone (CRH) (17) , and this effect is augmented by substance P (SP) (18) and neurotensin (NT) (19) , thus facilitating PDAC maintenance and expansion. In line with the association of pancreatitis with PDAC, genetically modified mouse models of PDAC have shown that cerulein-induced pancreatitis accelerates the development of PDAC (20) hastening also the process of metastasis (21) .
In this study, we aim to determine the number of MC and their degranulation state in PDAC in comparison to non-neoplastic pancreatic tissue from clear margins derived from the same patients, as well as to acute pancreatitis.
MATERIALS AND METHODS

Pancreatic tissue specimens
Surgical specimens of infiltrative PDAC of the pancreatic head (n = 7) and uninvolved, non-inflammatory pancreatic tissue (n=7) obtained from the corresponding cancer-free margin areas (10-15 mm) were collected at the time of Whipple operations. This was done under a protocol approved by the Attikon Hospital Human Ethics Committee, Athens, Greece, following informed consent from the involved patients and/or their guardian(s). Age-matched cases of AP (n=4) were provided by the Department of Pathology of Attikon Hospital, Athens, Greece. Demographic and clinicopathological characteristics were collected for all cases, without identifiers. The underlying diagnosis was based on standard histopathologic criteria as determined by experienced surgical pathologists.
Immunohistochemical (IHC) staining
Immunohistochemistry (lHC) was performed on formalin-fixed, paraffin-embedded pancreatic tissue tissue slides. The corresponding blocks were sectioned at a thickness of 7 urn, mounted on Superfrost Plus microscopic slides (Fisher Scientific, Pittsburgh, PA), and dried at 50°C for at least 24 h. Deparaffinization was achieved using xylene and rehydration with a graded ethanol series. Antigen retrieval was performed using an antigen-unmasking solution (Vector Laboratories, Burlingame, CA, USA). Endogenous peroxidases were then blocked using 3% HPz in distilled water for IS min. Following a 30-min blocking with the corresponding normal serum, sections were incubated at 4°C overnight with mouse monoclonal antibodies: (a) anti-human tryptase (Cat# MAB1222) at 1:4000 dilution and (b) antic-kit (DD-117) (Chemicon International, Temecula, CA, USA) at 1:250 dilution. These antibodies were used with DykoCytomation APAAP Kit System (Cat # K0670). The reaction was visualized using Vectastain Elite ABC Kit with diaminobenzidine chromogen as a substrate (Vector Laboratories, Burlingame, CA, USA). Sections were lightly counterstained with hematoxylin and mounted. Toluidine blue (0.1% at pH 2) was used at 24°C for 30 sec. Sections were photographed at high power field (HPF) using an upright Zeiss microscope.
Degranulation
MC were considered degranulated if they had lost 30% or more of their secretory granule content stainable by toluidine blue or tryptase, or by the presence of such material outside the cells.
Statistical analysis
Cells were counted in five HPFs. The results are presented as mean ± SD. The two-tailed Student's r-test was used to identify significant differences between independent groups, such as pathological states to controls using each MC stain at a time. This was followed by pairwise Wilcoxon Rank Sum test to determine which group differences were statistically significant, as defined by p < 0.05. All statistical analyses were performed utilizing SAS.
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RESULTS
Basic demographic and clinicopathological characteristics ofthe PDAC andAPpatients included in our study are shown in Table I .
The number ofMC detected in "normal" pancreatic tissue using c-kit was higher (9.7±5.I per HPF) compared to those identified by tryptase (4.5±3.5 per HPF) or toluidine blue (2.1±2.0 per HPF) (Table II,   Fig. I) . Of note, c-kit staining detects MC through their surface receptor for stem cell factor (c-kit or CD-II7) regardless of their degranulation status.
There was also a higher number ofMC in PDAC cases detected by c-kit staining (22.2±7.5 per HPF) as compared to those stained by tryptase (I2.4±5.I per HPF) or toluidine blue (7.0±2.7 per HPF) (Table  III) . Because c-kit may also stain PDAC cells, we counted the number of PDAC cells stained with c-kit. Only 13.5±8.5% of the total c-kit-stained cells were cancer cells and thus did not account for the increase in the MC number noted (Table III) . The number of MC at the invasive front of the tumors, as well as at the tumor center, was also investigated. The number of MC was higher in both the tumor center and the invasive front compared to the control normal pancreatic tissue; the invasive tumor edges revealed the highest cell concentration (Table IV) . No significant difference in the number of MC was detected when PDAC cases were stratified by tumor grade (Table IV) .
Of note, MC in PDAC were not degranulated (Fig. II) . In contrast, biopsies of acute pancreatitis revealed increased MC number stained with toluidine blue compared to the uninvolved clear margins, but unlike PDAC, these MC were degranulated (Fig.  III) .
DISCUSSION
Fig. 3. Photomicrographs showing mast cells stained with toluidine blue (arrows) in (A) uninvolved pancreatic tissue and (B) pancreatitis. Note that mast cells in B are largely degranulated as compared to control tissue. Bar = 30 Jim
This study provides evidence that MC accumulate, but do not degranulate in PDAC. We found that the number ofMC in the TME ofPDAC is significantly increased as compared to the tumor-free margins of the corresponding patients, and this increase does not differ significantly among the various degrees of tumor differentiation. This is in line with the previous correlation of PDAC aggressiveness with increased number of tryptase positive MC (7) . Staining with c-kit identified the greatest number of Me. In addition, only a small number of PDAC cells (13%) were found positive for c-kit in our study, which might indicate PDAC development, as similar lack of c-kit has been associated with the development of mammary adenocarcinoma in rats (22) . Significant increase in MC has also been reported for malignant versus benign lesions in human breast biopsies (23) . Similarly, patients with bronchial carcinoma exhibited increased number of MC in their bronchoalveolar lavage (24) , whereas increased MC density in lung adenocarcinoma, as detected by tryptase and surface CD34 lHC staining, correlated significantly with tumor progression, angiogenesis and poor prognosis (25) . The latter was also supported by a correlation of MC density with increased VEGF expression and poor prognosis in non-small cell lung carcinomas (26) . Mast cells were not found to be degranulated in PDAC, but this was not the case for AP. This implies that MC behave differently in these two clinical conditions; they secrete inflammatory mediators that contribute to the inflammation of AP, whereas MC around PDAC do not secrete such inflammatory mediators that could be detrimental to tumor growth. This finding has been also reported in human mammary adenocarcinoma, where MC number was increased but MC were not degranulated (3). Nevertheless, non-degranulated MC in PDAC could still release molecules conducive to tumor growth (3). For instance, MC can facilitate tumor angiogenesis through selective release of VPFNEGF (18, 27) , especially when stimulation through CRH (17) or NT (19) takes place. Such selective release occurs without degranulation (28) that would otherwise be accompanied by the release of molecules, such as TNF, which are detrimental for the tumor. In a similar fashion, MC can also secrete fibroblast growth factor-2 (FGF-2), nerve growth factor (NGF), platelet-derived growth factor (PDGF) and stem cell factor (SCF) (3), which is considered as a possible link between inflammation and cancer (28) .
Derived from a bone marrow progenitor (29) , MC undergo maturation in various tissues in response to microenvironmental conditions (30) . In addition to stimulation by IgE and specific antigens, MC can be also triggered by CRH, SP, endothelin, thrombin, tumor-derived adrenomedullin, bombesin, NT, somatostatin, and vasoactive intestinal peptide (VIP) (30, 31) , and thus, they can induce T-cell tolerance. In addition, MC are rich in metalloproteinases that contribute to the invasiveness of rat mammary adenocarcinoma through matrix degradation at sites of tumor invasiveness (4, 32) .
In conclusion, MC are increased, but not degranulated in PDAC as compared to unaffected pancreatic tissue derived from tumor-free margins of the corresponding PDAC cases or normal pancreatic tissue. This finding is in contrast to AP where MC were increased and degranulated. Inhibition of MC secretion of tumor promoting mediators may be a novel therapeutic approach for PDAC.
